Home > Insider Trading > Filing (0001209191-14-058829)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907654	Arca Biopharma Inc.	ABIO	In Vitro & In Vivo Diagnostic Substances (2835)	363855489

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266125	R Michael Bristow	Arca Biopharma, Inc. 11080 Circlepoint Road, Suite 140 Westminster CO 80020	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-09-18	13,853	$1.30	292,625	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	139,082	Indirect	By Investocor Trust as sole Trustee
Common Stock	178,215	Indirect	By NFS Custodian for Michael Bristow's IRA

Footnotes

Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person for satisfaction of their tax withholding obligation with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Equity Incentive Plan (the "Plan").
Includes (i) remaining 83,334 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments on 9/17/15 and 9/17/16, and (ii) 56,700 previously reported shares issued as RSUs under the Plan that vest in four equal annual installments beginning on 2/27/15, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan.